{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:25:31Z","timestamp":1773847531903,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 75-year-old woman presented with right lower abdominal pain. Pelvic ultrasound showed a cystic solid mass in the right adnexa. Painless enlarged lymph nodes on the left supraclavicular side with biopsy were suggestive of metastatic cancer. <jats:sup>18<\/jats:sup>F-FDG PET\/CT performed to evaluate the primary tumor showed intense uptake in both regions of the right adnexa and the gastric sinus, but <jats:sup>68<\/jats:sup>Ga-FAPI PET\/MRI showed uptake only in the right adnexal region. A subsequent gastroscopic biopsy confirmed atrophic inflammation. Finally, surgery histopathology revealed ovarian cancer. This case demonstrated that <jats:sup>68<\/jats:sup>Ga-FAPI PET\/MRI may help exclude suspected primary gastric carcinoma with false-positive <jats:sup>18<\/jats:sup>F-FDG uptake.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004656","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T20:25:19Z","timestamp":1681935919000},"page":"525-527","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["68Ga-FAPI-04 PET\/MR Versus 18F-FDG PET\/CT in the Detection of Ovarian Cancer"],"prefix":"10.1097","volume":"48","author":[{"given":"Gaofeng","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Changhai Hospital, Affiliated to the Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoyao","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangqing","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjing","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Changhai Hospital, Affiliated to the Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0256-4947.75771","article-title":"18F-FDG PET\/CT imaging in oncology","volume":"31","year":"2011","journal-title":"Ann Saudi Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","article-title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of Ga-FAPI and F-FDG PET\/CT in cancer patients","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","article-title":"68Ga-FAPI-PET\/CT in patients with various gynecological malignancies","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/RLU.0000000000003489","article-title":"Fibroblast activation protein inhibitor PET\/CT: a promising molecular imaging tool","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/RLU.0000000000003561","article-title":"Comparison of 68Ga-FAPI and 18F-FDG PET\/CT in the imaging of pancreatic cancer with liver metastases","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1148\/radiol.211424","article-title":"Comparison of 68Ga-FAPI and 18F-FDG PET\/CT in the evaluation of advanced lung cancer","volume":"303","year":"2022","journal-title":"Radiology"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1186\/s12885-020-07541-6","article-title":"High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer","volume":"20","year":"2020","journal-title":"BMC Cancer"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:43Z","timestamp":1750532503000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004656","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}